John Markels
Direktor/Vorstandsmitglied bei SANGAMO THERAPEUTICS, INC.
Vermögen: 161 775 $ am 31.05.2024
Profil
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. He is also a Director at Arcturus Therapeutics, Inc., Arcturus Therapeutics Ltd., and Arcturus Therapeutics Holdings, Inc. Previously, he served as the President-Global Vaccines at Merck & Co., Inc. Dr. Markels holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.06.2024 | 3 131 ( 0,01% ) | 121 514 $ | 31.05.2024 | |
| 04.06.2024 | 71 384 ( 0,03% ) | 40 261 $ | 31.05.2024 |
Aktive Positionen von John Markels
| Unternehmen | Position | Beginn |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.02.2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 08.12.2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John Markels
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.03.2022 |
Ausbildung von John Markels
| University of California, Berkeley | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
